首页 > 最新文献

Journal of Infection and Public Health最新文献

英文 中文
Acknowledgement to Reviewers 审稿人致谢
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-08 DOI: 10.1016/S1876-0341(26)00010-9
{"title":"Acknowledgement to Reviewers","authors":"","doi":"10.1016/S1876-0341(26)00010-9","DOIUrl":"10.1016/S1876-0341(26)00010-9","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 2","pages":"Article 103138"},"PeriodicalIF":4.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling the emergence of divergent mutants of SARS-CoV-2, “Omicron-like events”: A time-to-event analysis 模拟SARS-CoV-2分化突变体的出现,“类欧米克隆事件”:时间到事件的分析。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-08 DOI: 10.1016/j.jiph.2026.103140
Haruka Hayashi, Yuta Okada, Taishi Kayano, Katsuma Hayashi, Tetsuro Kobayashi, Hiroshi Nishiura

Background

During the COVID-19 pandemic, several divergent mutants including the Omicron (B.1.1.529) BA.1 variant emerged, having a distinct mechanism of emergence compared with pre-existing variants of concern. Apart from playing a major role in causing recurrent epidemic waves, the highly divergent mutants also contributed to changing the fate of the pandemic by exhibiting large differences in phenotypic characteristics among even closely related variants. Given that several different variants emerged during the pandemic, the present study aimed to quantitatively evaluate the risk of emergence of divergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants and understand the mechanism of such emergence.

Methods

Upon identifying the emergence of phylogenetically distinct variants in “Omicron-like events” that have been recognized to date, a time-to-event analysis was carried out to estimate the monthly hazard rate of emergence. Four statistical models were established and compared using the Akaike Information Criterion.

Results

The model using the number of hospitalized cases was determined to be the best fit. The risk of Omicron-like events is not independent of time; instead, the monthly risk of emergence is likely to increase over time due to an increasing number of infection events.

Conclusions

Ongoing virus genomic surveillance is vital, and possible prevention among immunosuppressed individuals should be considered.
背景:在2019冠状病毒病大流行期间,出现了包括Omicron (B.1.1.529) BA.1变体在内的几种不同的突变体,与先前存在的变体相比,它们具有不同的出现机制。高度分化的突变体除了在引起反复出现的流行病浪潮中发挥主要作用外,甚至在密切相关的变体之间也表现出表型特征的巨大差异,从而有助于改变大流行的命运。鉴于在大流行期间出现了几种不同的变体,本研究旨在定量评估发散性严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)突变体出现的风险,并了解其出现的机制。方法:在确定迄今为止已识别的“类欧米克隆事件”中出现的系统发育上不同的变异后,进行了事件时间分析,以估计每月出现的危险率。采用赤池信息准则建立了4个统计模型并进行了比较。结果:采用住院病例数模型拟合效果最佳。类似欧米克隆事件的风险并非与时间无关;相反,由于感染事件数量的增加,每月出现的风险可能会随着时间的推移而增加。结论:持续的病毒基因组监测至关重要,应考虑在免疫抑制个体中进行可能的预防。
{"title":"Modeling the emergence of divergent mutants of SARS-CoV-2, “Omicron-like events”: A time-to-event analysis","authors":"Haruka Hayashi,&nbsp;Yuta Okada,&nbsp;Taishi Kayano,&nbsp;Katsuma Hayashi,&nbsp;Tetsuro Kobayashi,&nbsp;Hiroshi Nishiura","doi":"10.1016/j.jiph.2026.103140","DOIUrl":"10.1016/j.jiph.2026.103140","url":null,"abstract":"<div><h3>Background</h3><div>During the COVID-19 pandemic, several divergent mutants including the Omicron (B.1.1.529) BA.1 variant emerged, having a distinct mechanism of emergence compared with pre-existing variants of concern. Apart from playing a major role in causing recurrent epidemic waves, the highly divergent mutants also contributed to changing the fate of the pandemic by exhibiting large differences in phenotypic characteristics among even closely related variants. Given that several different variants emerged during the pandemic, the present study aimed to quantitatively evaluate the risk of emergence of divergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants and understand the mechanism of such emergence.</div></div><div><h3>Methods</h3><div>Upon identifying the emergence of phylogenetically distinct variants in “Omicron-like events” that have been recognized to date, a time-to-event analysis was carried out to estimate the monthly hazard rate of emergence. Four statistical models were established and compared using the Akaike Information Criterion.</div></div><div><h3>Results</h3><div>The model using the number of hospitalized cases was determined to be the best fit. The risk of Omicron-like events is not independent of time; instead, the monthly risk of emergence is likely to increase over time due to an increasing number of infection events.</div></div><div><h3>Conclusions</h3><div>Ongoing virus genomic surveillance is vital, and possible prevention among immunosuppressed individuals should be considered.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103140"},"PeriodicalIF":4.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trade and containment policies during COVID-19: Disaggregated evidence for adaptive public health governance 2019冠状病毒病期间的贸易和遏制政策:适应性公共卫生治理的分类证据
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-07 DOI: 10.1016/j.jiph.2026.103130
Chao-Chin Chang , Tzu-Chi Chang , Chia-Lin Chang

Background

Containment policies, also known as non-pharmaceutical interventions (NPIs), are crucial in managing emerging infectious diseases; however, their broader economic, social, and health impacts remain insufficiently understood. Previous studies have largely relied on aggregate indices, masking policy-specific effects and limiting their usefulness for preparedness and adaptive governance.

Methods

This study investigates how disaggregated containment measures affected international trade and the continuity of essential goods as a component of public health resilience. Using data from 182 countries during 2020–2021, we analyzed nine NPIs from the Oxford COVID-19 Government Response Tracker and international trade statistics across four product categories. Two indices, a conventional arithmetic mean and a novel entropy-weighted index, were constructed to capture policy intensity and cross-country heterogeneity. Panel regression models with fixed- and random-effects specifications were used to assess policy impacts.

Findings

Containment policies had heterogeneous effects on trade. Workplace closures were associated with trade resilience through digital adaptation, whereas stay-at-home orders and transport suspensions disrupted food and agricultural trade, revealing vulnerabilities in supply chains critical to health security. International travel restrictions correlated positively with goods trade, reflecting substitution from service- to goods-based activities. The entropy-weighted index outperformed the arithmetic mean by capturing policy variability, especially during 2020 early crisis phase.

Interpretation

Disaggregating NPIs reveals that policy design, timing, and institutional context shape both trade performance and health resilience. Integrating information-sensitive metrics such as entropy weighting can improve surveillance and preparedness frameworks. Policymakers should balance epidemiological effectiveness with the protection of essential trade flows to ensure equitable and adaptive pandemic governance.
背景:遏制政策,也称为非药物干预措施(npi),对于管理新发传染病至关重要;然而,对其更广泛的经济、社会和健康影响的了解仍然不够充分。以前的研究在很大程度上依赖于汇总指数,掩盖了特定于政策的影响,限制了它们对准备和适应性治理的有用性。方法本研究调查了分类控制措施如何影响国际贸易和作为公共卫生复原力组成部分的必需品的连续性。利用来自182个国家2020-2021年的数据,我们分析了来自牛津COVID-19政府应对跟踪系统的9个npi和四个产品类别的国际贸易统计数据。我们构建了两个指数,一个是传统的算术平均值,一个是新的熵加权指数,以捕捉政策强度和跨国异质性。使用具有固定效应和随机效应规格的面板回归模型来评估政策影响。研究发现,遏制政策对贸易的影响不尽相同。通过数字化适应,工作场所关闭与贸易韧性有关,而居家令和运输暂停则扰乱了粮食和农业贸易,暴露出对卫生安全至关重要的供应链的脆弱性。国际旅行限制与货物贸易呈正相关,反映了以服务为基础的活动向以货物为基础的活动的替代。熵加权指数的表现优于算术平均值,因为它捕捉到了政策的可变性,尤其是在2020年危机早期阶段。分析npi揭示了政策设计、时机和制度背景对贸易绩效和健康弹性的影响。集成信息敏感度量(如熵权)可以改进监视和准备框架。决策者应在流行病学有效性与保护基本贸易流动之间取得平衡,以确保公平和适应性的大流行病治理。
{"title":"Trade and containment policies during COVID-19: Disaggregated evidence for adaptive public health governance","authors":"Chao-Chin Chang ,&nbsp;Tzu-Chi Chang ,&nbsp;Chia-Lin Chang","doi":"10.1016/j.jiph.2026.103130","DOIUrl":"10.1016/j.jiph.2026.103130","url":null,"abstract":"<div><h3>Background</h3><div>Containment policies, also known as non-pharmaceutical interventions (NPIs), are crucial in managing emerging infectious diseases; however, their broader economic, social, and health impacts remain insufficiently understood. Previous studies have largely relied on aggregate indices, masking policy-specific effects and limiting their usefulness for preparedness and adaptive governance.</div></div><div><h3>Methods</h3><div>This study investigates how disaggregated containment measures affected international trade and the continuity of essential goods as a component of public health resilience. Using data from 182 countries during 2020–2021, we analyzed nine NPIs from the Oxford COVID-19 Government Response Tracker and international trade statistics across four product categories. Two indices, a conventional arithmetic mean and a novel entropy-weighted index, were constructed to capture policy intensity and cross-country heterogeneity. Panel regression models with fixed- and random-effects specifications were used to assess policy impacts.</div></div><div><h3>Findings</h3><div>Containment policies had heterogeneous effects on trade. Workplace closures were associated with trade resilience through digital adaptation, whereas stay-at-home orders and transport suspensions disrupted food and agricultural trade, revealing vulnerabilities in supply chains critical to health security. International travel restrictions correlated positively with goods trade, reflecting substitution from service- to goods-based activities. The entropy-weighted index outperformed the arithmetic mean by capturing policy variability, especially during 2020 early crisis phase.</div></div><div><h3>Interpretation</h3><div>Disaggregating NPIs reveals that policy design, timing, and institutional context shape both trade performance and health resilience. Integrating information-sensitive metrics such as entropy weighting can improve surveillance and preparedness frameworks. Policymakers should balance epidemiological effectiveness with the protection of essential trade flows to ensure equitable and adaptive pandemic governance.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103130"},"PeriodicalIF":4.0,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology, clinical outcomes and mortality-associated factors of staphylococcal pneumonia in hospitalized Thai children: A nationwide retrospective analysis 2015–2023 泰国住院儿童葡萄球菌肺炎的流行病学、临床结局和死亡相关因素:2015-2023年全国回顾性分析
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-03 DOI: 10.1016/j.jiph.2025.103127
Sirapoom Niamsanit , Phanthila Sitthikarnkha , Leelawadee Techasatian , Suchaorn Saengnipanthkul , Pope Kosalaraksa , Kaewjai Thepsuthammarat , Rattapon Uppala

Background and aims

Staphylococcal pneumonia is a serious cause of morbidity and mortality in children worldwide, particularly in resource-limited settings. This study aimed to investigate the national epidemiology, clinical outcomes, and mortality-associated factors of pediatric staphylococcal pneumonia in Thailand.

Materials and methods

A nationwide retrospective study was conducted using the National Health Security Office (NHSO) database. All hospital admissions of children aged 1 month to < 18 years diagnosed with staphylococcal pneumonia (ICD-10-TM code J15.2) between 2015 and 2023 were included. Demographics, comorbidities, complications, interventions, and outcomes were analyzed. Multivariable logistic regression was used to identify factors independently associated with mortality.

Results

A total of 1718 admissions were analyzed. Annual admissions peaked at 249 in 2016 and were lowest at 129 in 2022. Most admissions were male (61.5 %) and infants under 1 year (34.2 %). Intubation was required in 60.9 % of cases, and 10.5 % underwent surgical interventions. The hospital mortality rate was 10.6 %. Factors associated with higher mortality included congenital heart disease (adjusted odds ratio [AOR] 3.57; 95 % CI 2.27–5.61), malignancy (AOR 4.13; 95 % CI 1.87–9.10), malnutrition (AOR 3.13; 95 % CI 1.45–6.75), acute respiratory distress syndrome (ARDS) (AOR 4.26; 95 % CI 2.23–8.14), septic shock (AOR 3.85; 95 % CI 2.52–5.90), acute renal failure (AOR 4.46; 95 % CI 2.72–7.30), disseminated intravascular coagulation (DIC) (AOR 2.13; 95 % CI 1.18–3.83), and need for endotracheal intubation (AOR 9.98; 95 % CI 4.50–22.15).

Conclusion

Pediatric staphylococcal pneumonia remains a significant clinical burden in Thailand, with high complication and mortality rates. Targeted interventions, particularly in high-risk populations, are essential to improve outcomes.
背景和目的葡萄球菌性肺炎是全世界儿童发病和死亡的一个严重原因,特别是在资源有限的地区。本研究旨在调查泰国儿童葡萄球菌性肺炎的全国流行病学、临床结果和死亡相关因素。材料与方法利用国家卫生安全办公室(NHSO)数据库进行了一项全国性的回顾性研究。纳入2015年至2023年期间所有住院诊断为葡萄球菌肺炎(ICD-10-TM代码J15.2)的1个月至 18岁儿童。分析了人口统计学、合并症、并发症、干预措施和结果。使用多变量逻辑回归来确定与死亡率独立相关的因素。结果共分析入院人数1718人。2016年全年入学人数达到249人的峰值,2022年最低,为129人。入院患者以男性(61.5% %)和1岁以下婴儿(34.2% %)居多。60.9% %的病例需要插管,10.5% %的病例需要手术干预。住院死亡率为10.6% %。与高死亡率相关的因素包括先天性心脏病(调整优势比[AOR] 3.57; 95 % CI 2.27-5.61)、恶性肿瘤(AOR 4.13; 95 % CI 1.87-9.10)、营养不良(AOR 3.13; 95 % CI 1.45-6.75)、急性呼吸窘迫综合征(ARDS) (AOR 4.26; 95 % CI 2.23-8.14)、感染性休克(AOR 3.85; 95 % CI 2.52-5.90)、急性肾功能衰竭(AOR 4.46; 95 % CI 2.72-7.30)、弥散性血管内凝血(AOR 2.13;95 % CI 1.18-3.83),需要气管插管(AOR 9.98; 95 % CI 4.50-22.15)。结论在泰国,儿童葡萄球菌肺炎仍然是一个重要的临床负担,其并发症和死亡率都很高。有针对性的干预措施,特别是针对高危人群的干预措施,对于改善结果至关重要。
{"title":"Epidemiology, clinical outcomes and mortality-associated factors of staphylococcal pneumonia in hospitalized Thai children: A nationwide retrospective analysis 2015–2023","authors":"Sirapoom Niamsanit ,&nbsp;Phanthila Sitthikarnkha ,&nbsp;Leelawadee Techasatian ,&nbsp;Suchaorn Saengnipanthkul ,&nbsp;Pope Kosalaraksa ,&nbsp;Kaewjai Thepsuthammarat ,&nbsp;Rattapon Uppala","doi":"10.1016/j.jiph.2025.103127","DOIUrl":"10.1016/j.jiph.2025.103127","url":null,"abstract":"<div><h3>Background and aims</h3><div>Staphylococcal pneumonia is a serious cause of morbidity and mortality in children worldwide, particularly in resource-limited settings. This study aimed to investigate the national epidemiology, clinical outcomes, and mortality-associated factors of pediatric staphylococcal pneumonia in Thailand.</div></div><div><h3>Materials and methods</h3><div>A nationwide retrospective study was conducted using the National Health Security Office (NHSO) database. All hospital admissions of children aged 1 month to &lt; 18 years diagnosed with staphylococcal pneumonia (ICD-10-TM code J15.2) between 2015 and 2023 were included. Demographics, comorbidities, complications, interventions, and outcomes were analyzed. Multivariable logistic regression was used to identify factors independently associated with mortality.</div></div><div><h3>Results</h3><div>A total of 1718 admissions were analyzed. Annual admissions peaked at 249 in 2016 and were lowest at 129 in 2022. Most admissions were male (61.5 %) and infants under 1 year (34.2 %). Intubation was required in 60.9 % of cases, and 10.5 % underwent surgical interventions. The hospital mortality rate was 10.6 %. Factors associated with higher mortality included congenital heart disease (adjusted odds ratio [AOR] 3.57; 95 % CI 2.27–5.61), malignancy (AOR 4.13; 95 % CI 1.87–9.10), malnutrition (AOR 3.13; 95 % CI 1.45–6.75), acute respiratory distress syndrome (ARDS) (AOR 4.26; 95 % CI 2.23–8.14), septic shock (AOR 3.85; 95 % CI 2.52–5.90), acute renal failure (AOR 4.46; 95 % CI 2.72–7.30), disseminated intravascular coagulation (DIC) (AOR 2.13; 95 % CI 1.18–3.83), and need for endotracheal intubation (AOR 9.98; 95 % CI 4.50–22.15).</div></div><div><h3>Conclusion</h3><div>Pediatric staphylococcal pneumonia remains a significant clinical burden in Thailand, with high complication and mortality rates. Targeted interventions, particularly in high-risk populations, are essential to improve outcomes.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103127"},"PeriodicalIF":4.0,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible tuberculous meningitis presenting with predominant voiding dysfunction in an elderly patient: A case report 以排尿功能障碍为主的老年患者可能的结核性脑膜炎一例报告
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-02 DOI: 10.1016/j.jiph.2025.103128
Fanwei Liu , Siqi Sun , Yonghu Zhang , Fang Wang , Xiou Yang , Bingli Zhang , Sitong Fan , Hongyu Jia
Tuberculous meningitis (TBM) typically presents with neurological symptoms. Voiding dysfunction in TBM is usually attributed to spinal cord involvement. We report a rare case of possible TBM co-existing with possible prostatic tuberculosis, presenting primarily with urinary symptoms in the absence of spinal pathology. A 69-year-old male presented with a two-year history of progressive urinary retention, urgency, and frequency. Initial management for benign prostatic hyperplasia was ineffective. He subsequently developed fever, headache, and dizziness. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis and elevated protein. Despite extensive testing, including CSF culture, Xpert MTB/RIF, and metagenomic next-generation sequencing (mNGS), no pathogen was identified. However, a history of untreated testicular tuberculosis, pulmonary nodules on CT, and a prostatic nodule on MRI raised suspicion of disseminated tuberculosis. A clinical diagnosis of possible TBM was made based on a Marais score of 11. An intensive anti-tuberculosis regimen including moxifloxacin and linezolid led to complete resolution of neurological and urinary symptoms. This case suggests that voiding dysfunction in TBM patients may stem from concurrent genitourinary tuberculosis rather than spinal cord involvement. It highlights the importance of considering hematogenous dissemination from latent genitourinary foci in elderly patients and the utility of the Marais criteria for the diagnosis of TBM when microbiological evidence is elusive.
结核性脑膜炎(TBM)通常表现为神经系统症状。TBM的排尿功能障碍通常归因于脊髓受累。我们报告一例罕见的结核病合并前列腺结核的病例,主要表现为泌尿系统症状,没有脊柱病理。一名69岁男性,有2年进行性尿潴留、尿急和尿频病史。良性前列腺增生的初始治疗是无效的。他随后出现发烧、头痛和头晕。脑脊液(CSF)分析显示淋巴细胞增多和蛋白升高。尽管进行了广泛的测试,包括CSF培养,Xpert MTB/RIF和宏基因组下一代测序(mNGS),但没有发现病原体。然而,未经治疗的睾丸结核史,CT上的肺结节和MRI上的前列腺结节引起了对播散性结核的怀疑。根据Marais评分为11分,临床诊断可能为TBM。包括莫西沙星和利奈唑胺在内的强化抗结核方案导致神经和泌尿系统症状的完全解决。本病例提示TBM患者的排尿功能障碍可能源于并发泌尿生殖系统结核,而不是脊髓受累。它强调了考虑老年患者潜伏性泌尿生殖系统病灶的血液传播的重要性,以及当微生物证据难以捉摸时,Marais诊断TBM标准的实用性。
{"title":"Possible tuberculous meningitis presenting with predominant voiding dysfunction in an elderly patient: A case report","authors":"Fanwei Liu ,&nbsp;Siqi Sun ,&nbsp;Yonghu Zhang ,&nbsp;Fang Wang ,&nbsp;Xiou Yang ,&nbsp;Bingli Zhang ,&nbsp;Sitong Fan ,&nbsp;Hongyu Jia","doi":"10.1016/j.jiph.2025.103128","DOIUrl":"10.1016/j.jiph.2025.103128","url":null,"abstract":"<div><div>Tuberculous meningitis (TBM) typically presents with neurological symptoms. Voiding dysfunction in TBM is usually attributed to spinal cord involvement. We report a rare case of possible TBM co-existing with possible prostatic tuberculosis, presenting primarily with urinary symptoms in the absence of spinal pathology. A 69-year-old male presented with a two-year history of progressive urinary retention, urgency, and frequency. Initial management for benign prostatic hyperplasia was ineffective. He subsequently developed fever, headache, and dizziness. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis and elevated protein. Despite extensive testing, including CSF culture, Xpert MTB/RIF, and metagenomic next-generation sequencing (mNGS), no pathogen was identified. However, a history of untreated testicular tuberculosis, pulmonary nodules on CT, and a prostatic nodule on MRI raised suspicion of disseminated tuberculosis. A clinical diagnosis of <strong>possible TBM</strong> was made based on a Marais score of 11. An intensive anti-tuberculosis regimen including moxifloxacin and linezolid led to complete resolution of neurological and urinary symptoms. This case suggests that voiding dysfunction in TBM patients may stem from concurrent genitourinary tuberculosis rather than spinal cord involvement. It highlights the importance of considering hematogenous dissemination from latent genitourinary foci in elderly patients and the utility of the Marais criteria for the diagnosis of TBM when microbiological evidence is elusive.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103128"},"PeriodicalIF":4.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of six fatal cases with advanced HIV and monkeypox virus co-infection in Beijing: A retrospective analysis 北京地区6例晚期HIV伴猴痘病毒合并感染致死性病例临床特点回顾性分析
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-02 DOI: 10.1016/j.jiph.2025.103126
Lulu Xing , Jialu Li , Yifan Guo , Ying Liu , Jiang Xiao , Hongxin Zhao

Background

Recent findings on the outbreak of mpox indicate that immunosuppressed people are at significantly higher risk of death. The aims of the research were to provide a summary of the clinical features of mpox fatal cases, explore the effects of immunosuppression, monkeypox virus (MPXV)/human immunodeficiency virus (HIV) co-infection, and delayed antiretroviral therapy (ART) on prognosis, and offer evidence-based recommendations to inform clinical practices.

Methods

Demographic information, detailed HIV disease characteristics, ART history, mpox clinical features, laboratory results, and radiological evaluations were retrospectively extracted from electronic medical records.

Results

Six fatal cases were men who have sex with men (MSM), with a median age of 35 years (range: 23–37 years). Their median CD4+ count was 51 cells/μL (range: 2–116 cells/μL). Of these cases, two were simultaneously diagnosed with MPXV/HIV infection, one was diagnosed with HIV infection and never initiated ART, and the other three had interrupted ART prior to mpox diagnosis. All patients started or restarted ART, with a medium time from initiation of ART to death being 52 days (range: 20–148 days). Besides such symptoms like skin lesions and lymphadenopathy, all of them developed severe complications, including bacterial co-infections (n = 5), pneumonia (n = 5), intestinal obstruction (n = 2), and ocular involvement (n = 3). The median intervals between symptom onset and hospitalization or death were 30 days (range: 6–36 days) and 59 days (range: 32–110 days), respectively, with all death being due to sepsis or related multiple organ failure.

Conclusion

The combination of MPXV with advanced HIV infection carries an excessive risk of death, generated by severe immunodeficiency that facilitates serious secondary infections and MPXV dissemination. Even if ART is initiated as soon as possible, immune function cannot be restored quickly enough to clear MPXV.
背景:最近关于麻疹暴发的调查结果表明,免疫抑制者的死亡风险明显更高。本研究旨在总结m痘致死性病例的临床特点,探讨免疫抑制、猴痘病毒(MPXV)/人类免疫缺陷病毒(HIV)合并感染和延迟抗逆转录病毒治疗(ART)对预后的影响,并为临床实践提供循证建议。方法回顾性提取电子病历中的人口统计信息、详细的HIV疾病特征、ART病史、mpox临床特征、实验室结果和影像学评价。结果6例死亡病例为男男性行为者(MSM),中位年龄35岁(范围23 ~ 37岁)。CD4+计数中位数为51个细胞/μL(范围2 ~ 116个细胞/μL)。在这些病例中,2例同时被诊断为MPXV/HIV感染,1例被诊断为HIV感染但从未开始抗逆转录病毒治疗,另外3例在m痘诊断之前中断了抗逆转录病毒治疗。所有患者开始或重新开始抗逆转录病毒治疗,从开始抗逆转录病毒治疗到死亡的中间时间为52天(范围:20-148天)。除皮肤病变、淋巴结病变等症状外,所有患者均出现严重并发症,包括细菌合并感染(n = 5)、肺炎(n = 5)、肠梗阻(n = 2)、眼部受累(n = 3)。从症状出现到住院或死亡的中位间隔时间分别为30天(范围6-36天)和59天(范围32-110天),所有死亡均因败血症或相关的多器官衰竭。结论MPXV合并晚期HIV感染具有过高的死亡风险,严重免疫缺陷导致严重继发感染和MPXV传播。即使尽早开始抗逆转录病毒治疗,免疫功能也不能迅速恢复到足以清除MPXV。
{"title":"Clinical characteristics of six fatal cases with advanced HIV and monkeypox virus co-infection in Beijing: A retrospective analysis","authors":"Lulu Xing ,&nbsp;Jialu Li ,&nbsp;Yifan Guo ,&nbsp;Ying Liu ,&nbsp;Jiang Xiao ,&nbsp;Hongxin Zhao","doi":"10.1016/j.jiph.2025.103126","DOIUrl":"10.1016/j.jiph.2025.103126","url":null,"abstract":"<div><h3>Background</h3><div>Recent findings on the outbreak of mpox indicate that immunosuppressed people are at significantly higher risk of death. The aims of the research were to provide a summary of the clinical features of mpox fatal cases, explore the effects of immunosuppression, monkeypox virus (MPXV)/human immunodeficiency virus (HIV) co-infection, and delayed antiretroviral therapy (ART) on prognosis, and offer evidence-based recommendations to inform clinical practices.</div></div><div><h3>Methods</h3><div>Demographic information, detailed HIV disease characteristics, ART history, mpox clinical features, laboratory results, and radiological evaluations were retrospectively extracted from electronic medical records.</div></div><div><h3>Results</h3><div>Six fatal cases were men who have sex with men (MSM), with a median age of 35 years (range: 23–37 years). Their median CD4<sup>+</sup> count was 51 cells/μL (range: 2–116 cells/μL). Of these cases, two were simultaneously diagnosed with MPXV/HIV infection, one was diagnosed with HIV infection and never initiated ART, and the other three had interrupted ART prior to mpox diagnosis. All patients started or restarted ART, with a medium time from initiation of ART to death being 52 days (range: 20–148 days). Besides such symptoms like skin lesions and lymphadenopathy, all of them developed severe complications, including bacterial co-infections (n = 5), pneumonia (n = 5), intestinal obstruction (n = 2), and ocular involvement (n = 3). The median intervals between symptom onset and hospitalization or death were 30 days (range: 6–36 days) and 59 days (range: 32–110 days), respectively, with all death being due to sepsis or related multiple organ failure.</div></div><div><h3>Conclusion</h3><div>The combination of MPXV with advanced HIV infection carries an excessive risk of death, generated by severe immunodeficiency that facilitates serious secondary infections and MPXV dissemination. Even if ART is initiated as soon as possible, immune function cannot be restored quickly enough to clear MPXV.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103126"},"PeriodicalIF":4.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated computational analysis for Escherichia coli prevalence, genetic evolution, and antimicrobial resistance evolution: Implications for public health and environmental sustainability in Asia 大肠杆菌流行、遗传进化和抗菌素耐药性进化的综合计算分析:对亚洲公共卫生和环境可持续性的影响。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-12-30 DOI: 10.1016/j.jiph.2025.103117
Ashwini Mallappa , Kuralayanapalya Puttahonnappa Suresh , Sharanagouda S. Patil , Shivasharanappa Nayakvadi , Baldev Raj Gulati , Raghavendra G. Amachawadi , Sudarshan Peramachanahalli Venkatesh , Yamini Sri Sekar , Archana Veeranagouda Patil

Background

Escherichia coli (E. coli), a common gut commensal, includes pathogenic strains responsible for gastrointestinal infections and hemolytic uremic syndrome (HUS). It spreads mainly through contaminated water and food, as well as direct human contact, with the risk being particularly high in densely populated regions. The growing emergence of antimicrobial-resistant (AMR) strains, particularly in Asia, poses serious public health challenges.

Methods

This study employed a multi-tiered computational framework comprising systematic review, quantitative evidence synthesis (meta-analysis), the Markov cluster algorithm with random walks on pan-genomics, and positive selection through evolutionary analysis, shedding light on the prevalence, geographical distribution, genomic diversity, and evolutionary dynamics of E. coli across Asia.

Results

Quantitative evidence synthesis (meta-analysis) technique included 66 articles (total sample n = 1,20,207) and revealed an E. coli prevalence of 18 % (95 % CI:14 %-21 %, I2=100, τ 2=0.0, P = 0) in Asia. The E. coli incidences identified the Indian strain Ec40 collected in 2013 showed the highest genetic diversity, and the sequences collected between 2012 and 2019 displayed the most variation. The emrY gene, recurrently identified within the E. coli genomes, was subjected to evolutionary analysis. Codon-based selection models indicated adaptive evolution, with five codon sites under pervasive selection and twelve under episode selection (ω > 1), suggesting antimicrobial pressure as the main driver of regional adaptation.

Conclusion

These findings underscore the urgent need for integrated prevention and control strategies, including robust surveillance systems to monitor infection trends, targeted interventions to curb transmission, and strengthened biosecurity measures aimed at reducing environmental contamination. Furthermore, the emergence of AMR variants calls for alternative treatment, e.g., bacteriophage therapy, to reduce the clinical and socioeconomic burden of E. coli infections in humans and animal populations.
背景:大肠杆菌是一种常见的肠道共生菌,包括导致胃肠道感染和溶血性尿毒症综合征(HUS)的致病菌株。它主要通过受污染的水和食物以及人类直接接触传播,在人口稠密地区风险特别高。抗微生物药物耐药性(AMR)菌株的日益出现,特别是在亚洲,构成了严重的公共卫生挑战。方法:本研究采用系统综述、定量证据综合(meta分析)、泛基因组随机行走马尔可夫聚类算法、进化分析正向选择等多层计算框架,揭示了大肠杆菌在亚洲的流行、地理分布、基因组多样性和进化动态。结果:定量证据合成(meta分析)技术纳入66篇文章(总样本n = 1,20,207),显示大肠杆菌在亚洲的患病率为18 %(95 % CI:14 %-21 %,I2=100, τ 2=0.0, P = 0)。2013年收集的印度菌株Ec40的大肠杆菌发病率显示出最高的遗传多样性,2012年至2019年收集的序列显示出最大的变异。emrY基因在大肠杆菌基因组中反复发现,并进行了进化分析。基于密码子的选择模型显示了适应性进化,其中5个密码子位点处于普遍选择状态,12个密码子位点处于插曲选择状态(ω > 1),表明抗微生物压力是区域适应的主要驱动因素。结论:这些发现强调迫切需要采取综合预防和控制战略,包括强有力的监测系统以监测感染趋势,有针对性的干预措施以遏制传播,以及加强旨在减少环境污染的生物安全措施。此外,抗菌素耐药性变体的出现要求采用替代治疗,例如噬菌体治疗,以减轻人类和动物群体中大肠杆菌感染的临床和社会经济负担。
{"title":"Integrated computational analysis for Escherichia coli prevalence, genetic evolution, and antimicrobial resistance evolution: Implications for public health and environmental sustainability in Asia","authors":"Ashwini Mallappa ,&nbsp;Kuralayanapalya Puttahonnappa Suresh ,&nbsp;Sharanagouda S. Patil ,&nbsp;Shivasharanappa Nayakvadi ,&nbsp;Baldev Raj Gulati ,&nbsp;Raghavendra G. Amachawadi ,&nbsp;Sudarshan Peramachanahalli Venkatesh ,&nbsp;Yamini Sri Sekar ,&nbsp;Archana Veeranagouda Patil","doi":"10.1016/j.jiph.2025.103117","DOIUrl":"10.1016/j.jiph.2025.103117","url":null,"abstract":"<div><h3>Background</h3><div><em>Escherichia coli</em> (<em>E. coli</em>), a common gut commensal, includes pathogenic strains responsible for gastrointestinal infections and hemolytic uremic syndrome (HUS). It spreads mainly through contaminated water and food, as well as direct human contact, with the risk being particularly high in densely populated regions. The growing emergence of antimicrobial-resistant (AMR) strains, particularly in Asia, poses serious public health challenges.</div></div><div><h3>Methods</h3><div>This study employed a multi-tiered computational framework comprising systematic review, quantitative evidence synthesis (meta-analysis), the Markov cluster algorithm with random walks on pan-genomics, and positive selection through evolutionary analysis, shedding light on the prevalence, geographical distribution, genomic diversity, and evolutionary dynamics of <em>E. coli</em> across Asia.</div></div><div><h3>Results</h3><div>Quantitative evidence synthesis (meta-analysis) technique included 66 articles (total sample n = 1,20,207) and revealed an <em>E. coli</em> prevalence of 18 % (95 % CI:14 %-21 %, I<sup>2</sup>=100, τ <sup>2</sup>=0.0, P = 0) in Asia. The <em>E</em>. <em>coli</em> incidences identified the Indian strain Ec40 collected in 2013 showed the highest genetic diversity, and the sequences collected between 2012 and 2019 displayed the most variation. The <em>emrY</em> gene, recurrently identified within the <em>E. coli</em> genomes, was subjected to evolutionary analysis. Codon-based selection models indicated adaptive evolution, with five codon sites under pervasive selection and twelve under episode selection (ω &gt; 1), suggesting antimicrobial pressure as the main driver of regional adaptation.</div></div><div><h3>Conclusion</h3><div>These findings underscore the urgent need for integrated prevention and control strategies, including robust surveillance systems to monitor infection trends, targeted interventions to curb transmission, and strengthened biosecurity measures aimed at reducing environmental contamination. Furthermore, the emergence of AMR variants calls for alternative treatment, e.g., bacteriophage therapy, to reduce the clinical and socioeconomic burden of <em>E. coli</em> infections in humans and animal populations.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103117"},"PeriodicalIF":4.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha 间日疟原虫疟疾的次优伯氨喹依从性:来自奥里萨邦高负担部落地区的证据
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-12-30 DOI: 10.1016/j.jiph.2025.103123
Anju Viswan K , Kannan Thiruvengadam , Rohit Sharma, Nandhini Perumalsamy, Renuka Devi Arumugam, Srikanth Srirama, Arya Rahul , Manju Rahi

Background

Eliminating Plasmodium vivax malaria in India’s tribal regions is challenging, mainly due to poor adherence to primaquine, the only hypnozoiticidal drug for radical cure under national policy. Incomplete adherence to the 14-day primaquine regimen leads to relapse, treatment failure, ongoing transmission, and may contribute to antimalarial resistance. This study quantified primaquine adherence, and explored behavioral factors influencing non-adherence in high-burden tribal districts of Odisha.

Methods

This prospective cohort study conducted from January to December 2024 in two high-burden tribal districts (Malkangiri, Koraput) enrolled 269 laboratory-confirmed P. vivax patients aged over one year. Structured questionnaires collected demographic, clinical, and treatment data. Adherence to the 14-day primaquine regimen was assessed on days 7 and 14 via self-report, pill counts, and blister pack inspection. Uni- and multivariable analyses identified predictors of non-adherence.

Results

Adherence to chloroquine (3 days) and artesunate–SP (mixed infections) exceeded 93 %, while only 58.7 % (95 % CI: 52.6–64.9) completed the 14-day primaquine course. Healthcare workers dispensed drugs according to guidelines. Treatment discontinuation was mainly due to symptom resolution (61.9 %) and forgetfulness (21.4 %); only one patient discontinued primaquine due to an adverse event. Older age and household malaria history were associated with better adherence.

Conclusion

Suboptimal primaquine adherence delays P. vivax elimination despite adequate drug supply and correct dosing. Addressing behavioral drivers of early treatment cessation is critical to interrupt relapse transmission. Programmatic focus should include intensified social behavior change communication, targeted directly observed therapy, and evaluation of shorter primaquine or single-dose tafenoquine treatments with G6PD testing to enhance radical cure and accelerate India’s 2030 malaria elimination goal.
背景:在印度部落地区划定间日疟原虫疟疾是一项挑战,主要是由于对伯氨喹的依从性差,而伯氨喹是国家政策下唯一用于根治的催眠杀虫药物。不完全坚持14天伯氨喹治疗方案会导致复发、治疗失败、持续传播,并可能导致抗疟药耐药性。本研究量化了奥里萨邦高负担部落地区的伯氨喹依从性,并探讨了影响不依从性的行为因素。方法本前瞻性队列研究于2024年1月至12月在两个高负担部落区(Malkangiri, Koraput)进行,纳入269例1岁以上实验室确诊的间日疟原虫患者。结构化问卷收集了人口统计、临床和治疗数据。在第7天和第14天通过自我报告、药片计数和泡罩包装检查来评估14天伯氨喹方案的依从性。单变量和多变量分析确定了不依从性的预测因素。结果氯喹(3 d)和青蒿琥酯- sp(混合感染)的依从率超过93 %,而完成伯氨喹14 d疗程的只有58.7 %(95 % CI: 52.6 ~ 64.9)。医护人员根据指南配药。停止治疗的主要原因是症状缓解(61.9 %)和健忘(21.4% %);只有一名患者因不良事件停用伯氨喹。年龄较大和家庭疟疾史与较好的依从性相关。结论尽管有充足的药物供应和正确的剂量,但非最佳的伯氨喹依从性会延迟间日疟的消除。解决早期停止治疗的行为驱动因素对于阻断复发传播至关重要。规划重点应包括加强社会行为改变沟通,有针对性的直接观察治疗,以及评估较短的伯氨喹或单剂量他非诺喹治疗与G6PD测试,以加强根治和加速印度2030年消除疟疾的目标。
{"title":"Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha","authors":"Anju Viswan K ,&nbsp;Kannan Thiruvengadam ,&nbsp;Rohit Sharma,&nbsp;Nandhini Perumalsamy,&nbsp;Renuka Devi Arumugam,&nbsp;Srikanth Srirama,&nbsp;Arya Rahul ,&nbsp;Manju Rahi","doi":"10.1016/j.jiph.2025.103123","DOIUrl":"10.1016/j.jiph.2025.103123","url":null,"abstract":"<div><h3>Background</h3><div>Eliminating <em>Plasmodium vivax</em> malaria in India’s tribal regions is challenging, mainly due to poor adherence to primaquine, the only hypnozoiticidal drug for radical cure under national policy. Incomplete adherence to the 14-day primaquine regimen leads to relapse, treatment failure, ongoing transmission, and may contribute to antimalarial resistance. This study quantified primaquine adherence, and explored behavioral factors influencing non-adherence in high-burden tribal districts of Odisha.</div></div><div><h3>Methods</h3><div>This prospective cohort study conducted from January to December 2024 in two high-burden tribal districts (Malkangiri, Koraput) enrolled 269 laboratory-confirmed <em>P. vivax</em> patients aged over one year. Structured questionnaires collected demographic, clinical, and treatment data. Adherence to the 14-day primaquine regimen was assessed on days 7 and 14 via self-report, pill counts, and blister pack inspection. Uni- and multivariable analyses identified predictors of non-adherence.</div></div><div><h3>Results</h3><div>Adherence to chloroquine (3 days) and artesunate–SP (mixed infections) exceeded 93 %, while only 58.7 % (95 % CI: 52.6–64.9) completed the 14-day primaquine course. Healthcare workers dispensed drugs according to guidelines. Treatment discontinuation was mainly due to symptom resolution (61.9 %) and forgetfulness (21.4 %); only one patient discontinued primaquine due to an adverse event. Older age and household malaria history were associated with better adherence.</div></div><div><h3>Conclusion</h3><div>Suboptimal primaquine adherence delays <em>P. vivax</em> elimination despite adequate drug supply and correct dosing. Addressing behavioral drivers of early treatment cessation is critical to interrupt relapse transmission. Programmatic focus should include intensified social behavior change communication, targeted directly observed therapy, and evaluation of shorter primaquine or single-dose tafenoquine treatments with G6PD testing to enhance radical cure and accelerate India’s 2030 malaria elimination goal.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103123"},"PeriodicalIF":4.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The genetic diversity of drug resistance in Mycobacterium tuberculosis strains from the Tibetan Plateau 青藏高原结核分枝杆菌耐药遗传多样性研究
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-12-29 DOI: 10.1016/j.jiph.2025.103120
Anyue Xia , Jie Luo , Xiaohui Yu , Sijuan Ding , Dongfang Feng , Bin Zhu , Maoshi Li , Shangshi Li , Li Shi , Huan Xu

Objective

This study aimed to characterize the genetic diversity of drug resistance in Mycobacterium tuberculosis (MTB) isolates from the Tibetan Plateau, elucidate the molecular epidemiological profile of tuberculosis (TB) in this high-altitude region, and offer a molecular basis to guide improved diagnostic, therapeutic, and preventive strategies.

Methods

A total of 169 clinical MTB isolates were collected from the General Hospital of Xizang Military Command between January 2024 and April 2025. Drug resistance-associated mutations were identified via targeted gene sequencing.

Results

Among the 169 isolates, the overall rate of genotypic resistance was 20.71 %, comprising mono-resistance (14.79 %), poly-resistance (1.78 %), and multidrug-resistance (MDR, 4.14 %). Retreated patients exhibited a higher resistance rate than newly treated cases (26.09 % vs. 14.29 %), with MDR exclusively identified in the retreatment group. Resistance to streptomycin was most prevalent (8.28 %), followed by isoniazid (7.69 %) and rifampicin (7.10 %). The predominant mutations observed were rpsL K43R and katG S315T. No mutations conferring resistance to second-line drugs were detected.

Conclusion

The substantial burden of drug-resistant TB on the Tibetan Plateau—particularly streptomycin resistance—underscores the critical need for implementing precision diagnostics and optimizing therapeutic regimens.
目的研究青藏高原结核分枝杆菌(MTB)耐药遗传多样性,阐明该地区结核病的分子流行病学特征,为改进诊断、治疗和预防策略提供分子基础。方法收集西藏军区总医院2024年1月~ 2025年4月临床结核分枝杆菌分离株169株。通过靶向基因测序鉴定耐药相关突变。结果169株菌株基因型总耐药率为20.71 %,其中单耐药(14.79 %)、多耐药(1.78 %)、多药耐药(4.14 %)。复发患者的耐药率高于新治疗患者(26.09 % vs. 14.29 %),耐多药仅在再治疗组中发现。链霉素耐药最多(8.28 %),其次是异烟肼(7.69 %)和利福平(7.10 %)。观察到的主要突变是rpsL K43R和katG S315T。未发现对二线药物产生耐药性的突变。结论青藏高原耐药结核病的巨大负担,特别是链霉素耐药性,强调了实施精确诊断和优化治疗方案的迫切需要。
{"title":"The genetic diversity of drug resistance in Mycobacterium tuberculosis strains from the Tibetan Plateau","authors":"Anyue Xia ,&nbsp;Jie Luo ,&nbsp;Xiaohui Yu ,&nbsp;Sijuan Ding ,&nbsp;Dongfang Feng ,&nbsp;Bin Zhu ,&nbsp;Maoshi Li ,&nbsp;Shangshi Li ,&nbsp;Li Shi ,&nbsp;Huan Xu","doi":"10.1016/j.jiph.2025.103120","DOIUrl":"10.1016/j.jiph.2025.103120","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to characterize the genetic diversity of drug resistance in <em>Mycobacterium tuberculosis</em> (MTB) isolates from the Tibetan Plateau, elucidate the molecular epidemiological profile of tuberculosis (TB) in this high-altitude region, and offer a molecular basis to guide improved diagnostic, therapeutic, and preventive strategies.</div></div><div><h3>Methods</h3><div>A total of 169 clinical MTB isolates were collected from the General Hospital of Xizang Military Command between January 2024 and April 2025. Drug resistance-associated mutations were identified via targeted gene sequencing.</div></div><div><h3>Results</h3><div>Among the 169 isolates, the overall rate of genotypic resistance was 20.71 %, comprising mono-resistance (14.79 %), poly-resistance (1.78 %), and multidrug-resistance (MDR, 4.14 %). Retreated patients exhibited a higher resistance rate than newly treated cases (26.09 % vs. 14.29 %), with MDR exclusively identified in the retreatment group. Resistance to streptomycin was most prevalent (8.28 %), followed by isoniazid (7.69 %) and rifampicin (7.10 %). The predominant mutations observed were <em>rpsL</em> K43R and <em>katG</em> S315T. No mutations conferring resistance to second-line drugs were detected.</div></div><div><h3>Conclusion</h3><div>The substantial burden of drug-resistant TB on the Tibetan Plateau—particularly streptomycin resistance—underscores the critical need for implementing precision diagnostics and optimizing therapeutic regimens.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103120"},"PeriodicalIF":4.0,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best Paper Award “Journal of Infection and Public Health” – 2025 Edition 最佳论文奖“感染与公共卫生杂志” - 2025年版
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-12-29 DOI: 10.1016/j.jiph.2025.103125
{"title":"Best Paper Award “Journal of Infection and Public Health” – 2025 Edition","authors":"","doi":"10.1016/j.jiph.2025.103125","DOIUrl":"10.1016/j.jiph.2025.103125","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 2","pages":"Article 103125"},"PeriodicalIF":4.0,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145920769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1